Tag | Content |
---|
EnhancerAtlas ID | HS129-04580 |
Organism | Homo sapiens |
Tissue/cell | MCF10A |
Coordinate | chr10:27069500-27071530 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CDX2 | MA0465.1 | chr10:27069687-27069698 | TTTTATGGCTC | - | 6.14 | Zfx | MA0146.2 | chr10:27071413-27071427 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_11168 | chr10:27066247-27077189 | CD20 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr10 | 27069683 | 27071117 | chr10 | 27069899 | 27070563 | chr10 | 27071142 | 27071286 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH10I026778 | chr10 | 27067685 | 27071880 |
|
Enhancer Sequence | AAGCAAATGT CTCTTGTTCA CTGGTGCAAA GCTACTCTCT CCCAGCCTCC CTCATCCCTC 60 AACCTCAGCT GCTTTATGAA GAAAGATGAT TAGGAGTGGG GCCAAGTTCT CCAAGTTCCC 120 AAAGGAGACT AAAGACCACA CACACCTGGG TAGGCTACAT AACTTTGGGG AGAGCACAGA 180 CTCAACATTT TATGGCTCTG TTGGATACAG GAGCCCAAGG CACCTTCATA CCCATCCTGT 240 GGAAGAATAA GTTACCAGCT TCCAACTGCT GAGGTCTGGG TAGGGTTCAA AGTAGGGAAG 300 GGAAGCTACT GTGACCTTTT GGGTGGGGCT CTTTGGACCA TTCAATGTAC TACTGTTTGT 360 AGCTTCCACT TCTGAGTGTA TAGTGGTATT GATATTTTAC AGGCCTGAAC TGTGAGGGCT 420 CATAAGCTCC AGGGAGATTA TGCTCACTGC GAATAGCCCA TGTAGAAAGG CATTAGTAGG 480 TTTGGGGCCC CACAATCCTT ATGACCTGTT TGAGTACAAG TCTGTGCACA GATGACTTTC 540 CTGACTAGAC CCTCTGGCAA GAGGAACAAC CTCTTCAGGT GACTCTTGGG TTTGGATTCA 600 ATGCCTCCCT GACGTAGCTA CTAGGTATGC CTCTTTTGAA AAGATTCCCA TTTGGGAATG 660 AGTCAACTCA AATGCAATGA CTAATAAGGT GGGAAAGGCC CAACAAGCCT CTGTCATCAC 720 ATGGAACTGG TAATATTCAA GAATGCAGCC AGTCTGGCCC CTAGGGCATC TCAGCTTTAC 780 ATGAAAAAGC AGCAGCTTCT CCCTTTGAGA AAGTCTGATC TTACATTCTG CCACCTAAAC 840 CAAATCTGCT AGCTCAGTGA GGCCCTTGAT TCACAGAGGT TCCCTAAATG CCTGGGCCTG 900 TTTCACTGAT GATTCAACTA AGCTGAGACG CTGTGGTGCC TAGTGGGCTG TAAACTCCAG 960 TGCCCATGAT ACAGAACTGA AAATGGGTGT GGTTGCTTTG TTCCACGGGC AAAACTCAAG 1020 GACATTCTCA CAGATCTGGC CAATATTCCC CTTGAAAACC TTGTTATATT TTTACTGACT 1080 ATCAGGCTAT TACCAACTGC CTAGGTATTT AGTCAGCCAC TTGGAAAACT ACAGAATGAC 1140 ATATTTAAGA CTGTCCAAAA ACCATGGAGA TCAATTGTAG TTGCTGATCA AACCATCTGG 1200 GTCACTAATA TAGATGTTTA CAGTAAGGGT CCATTGTCTG ATGAGACCAA TTATAATCAA 1260 GCCACTGATC AAGCTGCACG GTTAAGACTG CTACCACTGC TGCTGGATCC ATCATCATAC 1320 CAGACACAGC AACATATCTA TCATCATAGA GTGGATACAA AGTAAAAGAC TCTATGTTCC 1380 TGATGCAGAG GCTGCCACCT CATCCTAGAC TTATGAGTCC TGGAAAAGGA CTCATTTGTC 1440 TCATGGTGAG AGGAACCACA TCACATGCTA CTGGCAGATT GGTTGCATCA GACAACCTTC 1500 TTCAGGCTAT CAGTGGGGTC TCACTGCTGA TGACACTTTT CCAGGGTCTG GTACTGCTAT 1560 TCCAGTTCAA TCAGCTGACT CCAGCCACAG TACCGTGGTC CTTGACACTA ATCTGTGTCC 1620 TATTTTTACT TTCCACATCA TTTGCAATCT GACAATAGGT ACACCTTTTA TCACAAAAGT 1680 CACTCAACAA TGAGCTGTTA GTCAAGGTAG GTGACAGTCT ACCATCCACA GCATCTTATA 1740 TCGCTTAGTA CTGCAACAGC CTTATCAAAA ATCAGCTCAA AAAACCTCAA CAACAACAAA 1800 AAAAAAAACC CGACTCAAAA ATGGGCAAAA GACTTGACTA GACATTTCTC CAAAGAAGAC 1860 AGGCAAATAG AGGCCAGGCA CAGTGGCTCA CGCCTGTAAT CCCAACACTT TGGGAGGCCG 1920 AGGCGGGCAG ATCACAAGGT CAGGAGATGG AGACCATCCT GGCCAACATG GTGAAACCCC 1980 ATCTCTACCA AAAATACAAA CATTAGCTGG GCATGGTGGT GTGTGCCTGT 2030
|